Tivity Health - TVTY Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tivity Health in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TVTY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TVTY, but not buy additional shares or sell existing shares.
View TVTY analyst ratings or view top-rated stocks.

4 brokers have issued twelve-month price targets for Tivity Health's shares. Their TVTY share price forecasts range from $30.00 to $35.00. On average, they expect the company's share price to reach $32.00 in the next twelve months. This suggests that the stock has a possible downside of 1.5%.
View analysts price targets for TVTY or view top-rated stocks among Wall Street analysts.

Tivity Health's stock was trading at $26.44 at the beginning of the year. Since then, TVTY shares have increased by 22.9% and is now trading at $32.50.
View the best growth stocks for 2022 here.

Tivity Health, Inc. (NASDAQ:TVTY) announced its quarterly earnings results on Tuesday, November, 2nd. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.06. The business earned $126.29 million during the quarter, compared to analysts' expectations of $122.39 million. Tivity Health had a trailing twelve-month return on equity of 75.94% and a net margin of 17.25%. During the same quarter last year, the firm earned $0.72 EPS.

8 employees have rated Tivity Health Chief Executive Officer Richard Ashworth on Glassdoor.com. Richard Ashworth has an approval rating of 36% among the company's employees. This puts Richard Ashworth in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tivity Health investors own include NVIDIA (NVDA), Energy Transfer (ET), Pfizer (PFE), Advanced Micro Devices (AMD), AT&T (T), Sorrento Therapeutics (SRNE), Applied Materials (AMAT), Inovio Pharmaceuticals (INO) and Novavax (NVAX).

Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."

Shares of TVTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TVTY stock can currently be purchased for approximately $32.50.

Tivity Health (NASDAQ:TVTY) has a market capitalization of $1.62 billion and generates $481.25 million in revenue each year. The company earns $104.91 million in net income (profit) each year or $1.71 on an earnings per share basis.

Tivity Health employs 380 workers across the globe.

Tivity Health was founded in 2017.

Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The official website for the company is www.tivityhealth.com. The company can be reached via phone at (800) 869-5311, via email at investor.relations@tivityhealth.com, or via fax at 302-674-5266.